ERBB2 and breast carcinoma: Although some studies have found a connection between GRB2 and HER2‐overexpression breast cancer, highlighting the potential of GRB2 as a novel biomarker that stimulates tumor growth, limited data were available to elaborate on their interaction mechanisms.